The global breathable tape market is projected to reach a remarkable USD 8 billion by 2032, according to recent insights from ...

3M Co. is a technology ... commercial solutions, advanced materials, and transportation safety. The Health Care segment offers medical and surgical supplies, skin health and infection prevention ...

With subjects spanning intelligent drug discovery, medical robots, medical image identification and health data management, the IME programme is a multi-disciplinary, diverse platform for ...

What's Undetermined It's difficult to determine who was actually responsible for the stunt, given that 3M denies having any involvement and the marketing firm in question has not yet responded to ...

3M HIS will advance its conversational AI platform…[to] help deliver responsible, supportive ML-based clinical documentation and virtual assistant solutions that integrate directly into ...

For decades, there wasn’t an ideal way to manage the closed surgical incision environment to reduce the risk of those ...

3M (MMM) stock gained nearly 5% Tuesday and is up another 3% Wednesday, making one of the best-performing best Dow Jones stocks so far this week. The upside comes as the Post-It note maker's first ...

Bright-colored flowers beautify the south square of the National Exhibition and Convention Center, the main venue for the 7th China International Import Expo, in Shanghai on Oct 29, 2024.

In this article, we are going to take a look at where 3M Company (NYSE:MMM) stands against other best hurricane and natural disaster stocks to buy now. The 2024 hurricane season is shaping up to ...

Wall Street expects a year-over-year decline in earnings on lower revenues when 3M (MMM) reports results for the quarter ended September 2024. While this widely-known consensus outlook is ...

Mitosis is a process of nuclear division in eukaryotic cells that occurs when a parent cell divides to produce two identical daughter cells. During cell division, mitosis refers specifically to ...

With branded wound care manufacturers racing to build out their biologic and tissue-based therapies, AMS could have a hard time penetrating this niche, as it requires a different expertise than ...